JP2016501883A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016501883A5 JP2016501883A5 JP2015545858A JP2015545858A JP2016501883A5 JP 2016501883 A5 JP2016501883 A5 JP 2016501883A5 JP 2015545858 A JP2015545858 A JP 2015545858A JP 2015545858 A JP2015545858 A JP 2015545858A JP 2016501883 A5 JP2016501883 A5 JP 2016501883A5
- Authority
- JP
- Japan
- Prior art keywords
- thieno
- amino
- pyridine
- carboxamide
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 11
- -1 isocyano, nitro, amino Chemical group 0.000 claims 10
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 9
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims 8
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 8
- 125000003118 aryl group Chemical group 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 125000002252 acyl group Chemical group 0.000 claims 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 4
- 125000005251 aryl acyl group Chemical group 0.000 claims 4
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 claims 4
- 125000005170 cycloalkyloxycarbonyl group Chemical group 0.000 claims 4
- 125000005253 heteroarylacyl group Chemical group 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 4
- 239000001257 hydrogen Substances 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000011780 sodium chloride Substances 0.000 claims 4
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims 3
- 125000003342 alkenyl group Chemical group 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 125000000304 alkynyl group Chemical group 0.000 claims 3
- 125000003710 aryl alkyl group Chemical group 0.000 claims 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims 3
- 125000001072 heteroaryl group Chemical group 0.000 claims 3
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 3
- XNTAESPDXNOSPE-UHFFFAOYSA-N 3-amino-N,6-bis(4-chlorophenyl)thieno[2,3-b]pyridine-2-carboxamide Chemical compound C=1C=C2C(N)=C(C(=O)NC=3C=CC(Cl)=CC=3)SC2=NC=1C1=CC=C(Cl)C=C1 XNTAESPDXNOSPE-UHFFFAOYSA-N 0.000 claims 2
- MPYDTAKQTJCYMA-UHFFFAOYSA-N 3-amino-N-(4-bromophenyl)-6-(4-chlorophenyl)thieno[2,3-b]pyridine-2-carboxamide Chemical compound C=1C=C2C(N)=C(C(=O)NC=3C=CC(Br)=CC=3)SC2=NC=1C1=CC=C(Cl)C=C1 MPYDTAKQTJCYMA-UHFFFAOYSA-N 0.000 claims 2
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 claims 2
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 claims 2
- 206010012310 Dengue fever Diseases 0.000 claims 2
- 241000725619 Dengue virus Species 0.000 claims 2
- 208000001756 Virus Disease Diseases 0.000 claims 2
- 125000004442 acylamino group Chemical group 0.000 claims 2
- 125000003282 alkyl amino group Chemical group 0.000 claims 2
- 125000001769 aryl amino group Chemical group 0.000 claims 2
- 125000004657 aryl sulfonyl amino group Chemical group 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 125000006310 cycloalkyl amino group Chemical group 0.000 claims 2
- 201000002949 dengue disease Diseases 0.000 claims 2
- 125000004663 dialkyl amino group Chemical group 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 125000005241 heteroarylamino group Chemical group 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 2
- 235000019260 propionic acid Nutrition 0.000 claims 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 2
- 125000004463 2,4-dimethyl-thiazol-5-yl group Chemical group CC=1SC(=C(N1)C)* 0.000 claims 1
- LCFGVXANCKUZJX-UHFFFAOYSA-N 2-[N-(3-amino-6-thiophen-2-ylthieno[2,3-b]pyridine-2-carbonyl)-3-(trifluoromethyl)anilino]acetic acid Chemical compound C=1C=C2C(N)=C(C(=O)N(CC(O)=O)C=3C=C(C=CC=3)C(F)(F)F)SC2=NC=1C1=CC=CS1 LCFGVXANCKUZJX-UHFFFAOYSA-N 0.000 claims 1
- 125000006276 2-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C(*)C([H])=C1[H] 0.000 claims 1
- 125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims 1
- MCDIZEGYBFVWOK-UHFFFAOYSA-N 3,5-diamino-N-(5-phenyl-1,3,4-thiadiazol-2-yl)thieno[2,3-b]pyridine-2-carboxamide Chemical compound S1C2=NC=C(N)C=C2C(N)=C1C(=O)NC(S1)=NN=C1C1=CC=CC=C1 MCDIZEGYBFVWOK-UHFFFAOYSA-N 0.000 claims 1
- VUKUIZBMXWMXFX-UHFFFAOYSA-N 3-(N-[3-amino-6-(4-chlorophenyl)thieno[2,3-b]pyridine-2-carbonyl]-4-bromoanilino)propanoic acid Chemical compound C=1C=C2C(N)=C(C(=O)N(CCC(O)=O)C=3C=CC(Br)=CC=3)SC2=NC=1C1=CC=C(Cl)C=C1 VUKUIZBMXWMXFX-UHFFFAOYSA-N 0.000 claims 1
- SNFGEKZZSGJGBG-UHFFFAOYSA-N 3-[N-(3-amino-6-thiophen-2-ylthieno[2,3-b]pyridine-2-carbonyl)-3-(trifluoromethyl)anilino]propanoic acid Chemical compound C=1C=C2C(N)=C(C(=O)N(CCC(O)=O)C=3C=C(C=CC=3)C(F)(F)F)SC2=NC=1C1=CC=CS1 SNFGEKZZSGJGBG-UHFFFAOYSA-N 0.000 claims 1
- HOKLVNXVCQSSAN-UHFFFAOYSA-N 3-[N-[3-amino-6-(3-methoxyphenyl)thieno[2,3-b]pyridine-2-carbonyl]-4-(trifluoromethoxy)anilino]propanoic acid Chemical compound COC1=CC=CC(C=2N=C3SC(=C(N)C3=CC=2)C(=O)N(CCC(O)=O)C=2C=CC(OC(F)(F)F)=CC=2)=C1 HOKLVNXVCQSSAN-UHFFFAOYSA-N 0.000 claims 1
- NDGVXZHIZIUDQQ-UHFFFAOYSA-N 3-amino-2-[(5-phenyl-1,3,4-thiadiazol-2-yl)carbamoyl]thieno[2,3-b]pyridine-5-carboxylic acid Chemical compound S1C2=NC=C(C(O)=O)C=C2C(N)=C1C(=O)NC(S1)=NN=C1C1=CC=CC=C1 NDGVXZHIZIUDQQ-UHFFFAOYSA-N 0.000 claims 1
- MXLZVYYKPDMFBB-UHFFFAOYSA-N 3-amino-4-methoxy-N-(5-phenyl-1,3,4-thiadiazol-2-yl)thieno[2,3-b]pyridine-2-carboxamide Chemical compound NC=1C=2C(OC)=CC=NC=2SC=1C(=O)NC(S1)=NN=C1C1=CC=CC=C1 MXLZVYYKPDMFBB-UHFFFAOYSA-N 0.000 claims 1
- ZGMWBQBYKMJQOB-UHFFFAOYSA-N 3-amino-5-hydroxy-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]thieno[3,2-e]pyridine-2-carboxamide Chemical compound S1C2=NC=3CCCCC(O)C=3C=C2C(N)=C1C(=O)NC(S1)=NN=C1C1=CC=CC=C1 ZGMWBQBYKMJQOB-UHFFFAOYSA-N 0.000 claims 1
- CKYUFAYVYUXPJA-UHFFFAOYSA-N 3-amino-5-oxo-N-(5-phenyl-1,3,4-thiadiazol-2-yl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]thieno[3,2-e]pyridine-2-carboxamide Chemical compound S1C2=NC=3CCCCC(=O)C=3C=C2C(N)=C1C(=O)NC(S1)=NN=C1C1=CC=CC=C1 CKYUFAYVYUXPJA-UHFFFAOYSA-N 0.000 claims 1
- KNOXMIMQBHGUMQ-UHFFFAOYSA-N 3-amino-6-(1,3-benzodioxol-5-yl)-N-(2-bromo-4-methylphenyl)thieno[2,3-b]pyridine-2-carboxamide Chemical compound BrC1=CC(C)=CC=C1NC(=O)C1=C(N)C2=CC=C(C=3C=C4OCOC4=CC=3)N=C2S1 KNOXMIMQBHGUMQ-UHFFFAOYSA-N 0.000 claims 1
- JPNLDJUBHQCXBA-UHFFFAOYSA-N 3-amino-6-(3-methoxyphenyl)-N-[4-(trifluoromethoxy)phenyl]thieno[2,3-b]pyridine-2-carboxamide Chemical compound COC1=CC=CC(C=2N=C3SC(=C(N)C3=CC=2)C(=O)NC=2C=CC(OC(F)(F)F)=CC=2)=C1 JPNLDJUBHQCXBA-UHFFFAOYSA-N 0.000 claims 1
- LHSDGLRNODSUHS-UHFFFAOYSA-N 3-amino-6-(4-chlorophenyl)-N-(2,3-dichlorophenyl)thieno[2,3-b]pyridine-2-carboxamide Chemical compound C=1C=C2C(N)=C(C(=O)NC=3C(=C(Cl)C=CC=3)Cl)SC2=NC=1C1=CC=C(Cl)C=C1 LHSDGLRNODSUHS-UHFFFAOYSA-N 0.000 claims 1
- AIRAIJSHUNKACH-UHFFFAOYSA-N 3-amino-6-(4-chlorophenyl)-N-(3,4-dimethylphenyl)thieno[2,3-b]pyridine-2-carboxamide Chemical compound C1=C(C)C(C)=CC=C1NC(=O)C1=C(N)C2=CC=C(C=3C=CC(Cl)=CC=3)N=C2S1 AIRAIJSHUNKACH-UHFFFAOYSA-N 0.000 claims 1
- SCIZKGYHKPMVJA-UHFFFAOYSA-N 3-amino-6-(4-chlorophenyl)-N-(4-hydroxyphenyl)thieno[2,3-b]pyridine-2-carboxamide Chemical compound C=1C=C2C(N)=C(C(=O)NC=3C=CC(O)=CC=3)SC2=NC=1C1=CC=C(Cl)C=C1 SCIZKGYHKPMVJA-UHFFFAOYSA-N 0.000 claims 1
- QHEFGRKZJVYUNP-UHFFFAOYSA-N 3-amino-6-(4-chlorophenyl)-N-[4-(1,1-difluoroethyl)phenyl]thieno[2,3-b]pyridine-2-carboxamide Chemical compound C1=CC(C(F)(F)C)=CC=C1NC(=O)C1=C(N)C2=CC=C(C=3C=CC(Cl)=CC=3)N=C2S1 QHEFGRKZJVYUNP-UHFFFAOYSA-N 0.000 claims 1
- RYXOLLQLNXXYKS-UHFFFAOYSA-N 3-amino-6-(4-chlorophenyl)-N-[4-(2,2,2-trifluoroacetyl)phenyl]thieno[2,3-b]pyridine-2-carboxamide Chemical compound C=1C=C2C(N)=C(C(=O)NC=3C=CC(=CC=3)C(=O)C(F)(F)F)SC2=NC=1C1=CC=C(Cl)C=C1 RYXOLLQLNXXYKS-UHFFFAOYSA-N 0.000 claims 1
- QNRUSQOBAHFIEE-UHFFFAOYSA-N 3-amino-6-(4-chlorophenyl)-N-[4-(difluoromethoxy)phenyl]thieno[2,3-b]pyridine-2-carboxamide Chemical compound C=1C=C2C(N)=C(C(=O)NC=3C=CC(OC(F)F)=CC=3)SC2=NC=1C1=CC=C(Cl)C=C1 QNRUSQOBAHFIEE-UHFFFAOYSA-N 0.000 claims 1
- CFRWNHJFWJWWDG-UHFFFAOYSA-N 3-amino-6-(trifluoromethyl)-N-[3-(trifluoromethyl)phenyl]thieno[2,3-b]pyridine-2-carboxamide Chemical compound S1C2=NC(C(F)(F)F)=CC=C2C(N)=C1C(=O)NC1=CC=CC(C(F)(F)F)=C1 CFRWNHJFWJWWDG-UHFFFAOYSA-N 0.000 claims 1
- HYYKFLNLVBEYPL-UHFFFAOYSA-N 3-amino-6-[3-(difluoromethoxy)phenyl]-N-[4-(difluoromethoxy)phenyl]thieno[2,3-b]pyridine-2-carboxamide Chemical compound C=1C=C2C(N)=C(C(=O)NC=3C=CC(OC(F)F)=CC=3)SC2=NC=1C1=CC=CC(OC(F)F)=C1 HYYKFLNLVBEYPL-UHFFFAOYSA-N 0.000 claims 1
- CUMDBGFMCPBWQP-UHFFFAOYSA-N 3-amino-6-[3-(difluoromethoxy)phenyl]-N-[4-(trifluoromethoxy)phenyl]thieno[2,3-b]pyridine-2-carboxamide Chemical compound C=1C=C2C(N)=C(C(=O)NC=3C=CC(OC(F)(F)F)=CC=3)SC2=NC=1C1=CC=CC(OC(F)F)=C1 CUMDBGFMCPBWQP-UHFFFAOYSA-N 0.000 claims 1
- WVNUJGBJACCANV-UHFFFAOYSA-N 3-amino-6-[3-(trifluoromethoxy)phenyl]-N-[4-(trifluoromethoxy)phenyl]thieno[2,3-b]pyridine-2-carboxamide Chemical compound C=1C=C2C(N)=C(C(=O)NC=3C=CC(OC(F)(F)F)=CC=3)SC2=NC=1C1=CC=CC(OC(F)(F)F)=C1 WVNUJGBJACCANV-UHFFFAOYSA-N 0.000 claims 1
- KMZMTCNWFUJBNJ-UHFFFAOYSA-N 3-amino-6-chloro-N-(5-phenyl-1,3,4-thiadiazol-2-yl)thieno[2,3-b]pyridine-2-carboxamide Chemical compound S1C2=NC(Cl)=CC=C2C(N)=C1C(=O)NC(S1)=NN=C1C1=CC=CC=C1 KMZMTCNWFUJBNJ-UHFFFAOYSA-N 0.000 claims 1
- HHYFXDUSKRMHCQ-UHFFFAOYSA-N 3-amino-6-methyl-N-(5-phenyl-1,3,4-thiadiazol-2-yl)thieno[2,3-b]pyridine-2-carboxamide Chemical compound S1C2=NC(C)=CC=C2C(N)=C1C(=O)NC(S1)=NN=C1C1=CC=CC=C1 HHYFXDUSKRMHCQ-UHFFFAOYSA-N 0.000 claims 1
- ITSKGMKPRYFWAL-UHFFFAOYSA-N 3-amino-6-thiophen-2-yl-N'-[3-(trifluoromethyl)phenyl]thieno[2,3-b]pyridine-2-carboximidamide Chemical compound C=1C=C2C(N)=C(C(=N)NC=3C=C(C=CC=3)C(F)(F)F)SC2=NC=1C1=CC=CS1 ITSKGMKPRYFWAL-UHFFFAOYSA-N 0.000 claims 1
- HCNPMXXHNSGZIL-UHFFFAOYSA-N 3-amino-N-(3-chlorophenyl)-6-(4-chlorophenyl)thieno[2,3-b]pyridine-2-carboxamide Chemical compound C=1C=C2C(N)=C(C(=O)NC=3C=C(Cl)C=CC=3)SC2=NC=1C1=CC=C(Cl)C=C1 HCNPMXXHNSGZIL-UHFFFAOYSA-N 0.000 claims 1
- WCKRWUUQCCSAKL-UHFFFAOYSA-N 3-amino-N-(4-bromophenyl)-5-cyano-4-(furan-2-yl)-6-oxo-7H-thieno[2,3-b]pyridine-2-carboxamide Chemical compound C=12C(N)=C(C(=O)NC=3C=CC(Br)=CC=3)SC2=NC(O)=C(C#N)C=1C1=CC=CO1 WCKRWUUQCCSAKL-UHFFFAOYSA-N 0.000 claims 1
- BXDYNMJWHMRNSX-UHFFFAOYSA-N 3-amino-N-(4-bromophenyl)-6-(3-methoxyphenyl)thieno[2,3-b]pyridine-2-carboxamide Chemical compound COC1=CC=CC(C=2N=C3SC(=C(N)C3=CC=2)C(=O)NC=2C=CC(Br)=CC=2)=C1 BXDYNMJWHMRNSX-UHFFFAOYSA-N 0.000 claims 1
- SXPPZGHBPQOEFB-UHFFFAOYSA-N 3-amino-N-methyl-6-thiophen-2-yl-N-[3-(trifluoromethyl)phenyl]thieno[2,3-b]pyridine-2-carboxamide Chemical compound C=1C=CC(C(F)(F)F)=CC=1N(C)C(=O)C(=C(C1=CC=2)N)SC1=NC=2C1=CC=CS1 SXPPZGHBPQOEFB-UHFFFAOYSA-N 0.000 claims 1
- FXTSYHIBGLLDBP-UHFFFAOYSA-N 4-[[3-amino-6-(4-chlorophenyl)thieno[2,3-b]pyridine-2-carbonyl]amino]benzenesulfonic acid Chemical compound C=1C=C2C(N)=C(C(=O)NC=3C=CC(=CC=3)S(O)(=O)=O)SC2=NC=1C1=CC=C(Cl)C=C1 FXTSYHIBGLLDBP-UHFFFAOYSA-N 0.000 claims 1
- JZGXAEVJGRCVBU-UHFFFAOYSA-N 4-[[3-amino-6-(4-chlorophenyl)thieno[2,3-b]pyridine-2-carbonyl]amino]benzoic acid Chemical compound C=1C=C2C(N)=C(C(=O)NC=3C=CC(=CC=3)C(O)=O)SC2=NC=1C1=CC=C(Cl)C=C1 JZGXAEVJGRCVBU-UHFFFAOYSA-N 0.000 claims 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- PDFMOOJJTZAUJW-UHFFFAOYSA-N 7-thiophen-2-yl-3-[3-(trifluoromethyl)phenyl]-1H-pyrido[2,3]thieno[2,4-b]pyrimidine-2,4-dione Chemical compound FC(F)(F)C1=CC=CC(N2C(C=3SC4=NC(=CC=C4C=3NC2=O)C=2SC=CC=2)=O)=C1 PDFMOOJJTZAUJW-UHFFFAOYSA-N 0.000 claims 1
- XKKXSBRHLNKTRI-UHFFFAOYSA-N 8-thiophen-2-yl-4-[3-(trifluoromethyl)phenyl]-1,3-dihydropyrido[2,3]thieno[2,4-d][1,4]diazepine-2,5-dione Chemical compound FC(F)(F)C1=CC=CC(N2C(C3=C(C4=CC=C(N=C4S3)C=3SC=CC=3)NC(=O)C2)=O)=C1 XKKXSBRHLNKTRI-UHFFFAOYSA-N 0.000 claims 1
- XAKFZIQEDWJGJW-UHFFFAOYSA-N C1CCCCC2=C1N=C1SC(C(=O)NC(C)(C)C)=C(N)C1=C2 Chemical compound C1CCCCC2=C1N=C1SC(C(=O)NC(C)(C)C)=C(N)C1=C2 XAKFZIQEDWJGJW-UHFFFAOYSA-N 0.000 claims 1
- SKIOPINUHKJQNC-UHFFFAOYSA-N C1CCCCC2=C1N=C1SC(C(=O)NCCCC)=C(N)C1=C2 Chemical compound C1CCCCC2=C1N=C1SC(C(=O)NCCCC)=C(N)C1=C2 SKIOPINUHKJQNC-UHFFFAOYSA-N 0.000 claims 1
- 208000001490 Dengue Diseases 0.000 claims 1
- NIXFRGRJJLIETE-UHFFFAOYSA-N FC(F)Oc1ccc(NC(=O)c2cc3cccnc3s2)cc1 Chemical compound FC(F)Oc1ccc(NC(=O)c2cc3cccnc3s2)cc1 NIXFRGRJJLIETE-UHFFFAOYSA-N 0.000 claims 1
- 102000014150 Interferons Human genes 0.000 claims 1
- 108010050904 Interferons Proteins 0.000 claims 1
- LGKUYONKCJRBRU-UHFFFAOYSA-N O=C(NC1=NN=C(S1)C1=CC=CC=C1)C1=CC2=CC=CN=C2S1 Chemical compound O=C(NC1=NN=C(S1)C1=CC=CC=C1)C1=CC2=CC=CN=C2S1 LGKUYONKCJRBRU-UHFFFAOYSA-N 0.000 claims 1
- 206010037660 Pyrexia Diseases 0.000 claims 1
- BBGJLRNRYUBSQF-UHFFFAOYSA-N S1C(=CC=2C1=NC=CC=2)C(=O)NC1=CC(=CC=C1)C(F)(F)F Chemical compound S1C(=CC=2C1=NC=CC=2)C(=O)NC1=CC(=CC=C1)C(F)(F)F BBGJLRNRYUBSQF-UHFFFAOYSA-N 0.000 claims 1
- YWRIATFFDFUQCS-UHFFFAOYSA-N S1C2=NC=3CCCCC(F)C=3C=C2C(N)=C1C(=O)NC(S1)=NN=C1C1=CC=CC=C1 Chemical compound S1C2=NC=3CCCCC(F)C=3C=C2C(N)=C1C(=O)NC(S1)=NN=C1C1=CC=CC=C1 YWRIATFFDFUQCS-UHFFFAOYSA-N 0.000 claims 1
- JECJMCIQCXXWFM-UHFFFAOYSA-N S1C2=NC=3CCCCCC=3C=C2C(N)=C1C(=O)NC1CCCCC1 Chemical compound S1C2=NC=3CCCCCC=3C=C2C(N)=C1C(=O)NC1CCCCC1 JECJMCIQCXXWFM-UHFFFAOYSA-N 0.000 claims 1
- 208000009714 Severe Dengue Diseases 0.000 claims 1
- 206010047461 Viral infection Diseases 0.000 claims 1
- 125000004423 acyloxy group Chemical group 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 1
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 claims 1
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 239000003443 antiviral agent Substances 0.000 claims 1
- 125000005135 aryl sulfinyl group Chemical group 0.000 claims 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims 1
- 125000005279 aryl sulfonyloxy group Chemical group 0.000 claims 1
- 125000005110 aryl thio group Chemical group 0.000 claims 1
- 125000004104 aryloxy group Chemical group 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 201000002950 dengue hemorrhagic fever Diseases 0.000 claims 1
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000005553 heteroaryloxy group Chemical group 0.000 claims 1
- 125000005842 heteroatoms Chemical group 0.000 claims 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
- 229940079322 interferon Drugs 0.000 claims 1
- 125000002462 isocyano group Chemical group *[N+]#[C-] 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- IBBMAWULFFBRKK-UHFFFAOYSA-N picolinamide Chemical compound NC(=O)C1=CC=CC=N1 IBBMAWULFFBRKK-UHFFFAOYSA-N 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- RXGHULSMJIVVTA-UHFFFAOYSA-N thieno[2,3-b]pyridine-2-carboxamide Chemical compound C1=CN=C2SC(C(=O)N)=CC2=C1 RXGHULSMJIVVTA-UHFFFAOYSA-N 0.000 claims 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- 229960005486 vaccines Drugs 0.000 claims 1
- 230000017613 viral reproduction Effects 0.000 claims 1
Claims (12)
式中、Xは、O、S及びN−R’からなる群より選択され、R’は、水素、アルキル、アルケニル、アルキニル、シクロアルキル、ヘテロシクロアルキル、アリールアルキル、アリール、ヘテロアリール、アシル、アリールアシル、ヘテロアリールアシル、スルホニル、アミノスルホニル、置換アミノスルホニル、アルコキシカルボニル、シクロアルキルオキシカルボニル、アリールオキシカルボニル、カルバモイル及び置換カルバモイル、からなる群より選択され、
Rは、ハロゲン、シアノ、イソシアノ、ニトロ、アミノ、アルキルアミノ、ジアルキルアミノ、シクロアルキルアミノ、ヘテロシクロアルキルアミノ、アリールアミノ、ヘテロアリールアミノ、アシルアミノ、アリールアシルアミノ、ヘテロアリールアシルアミノ、アルキルスルホニルアミノ、アリールスルホニルアミノ、ヒドロキシスルホニル、アミノスルホニル、置換アミノスルホニル、アシル、アリールアシル、ヘテロアリールアシル、カルボキシ、アルコキシカルボニル、シクロアルキルオキシカルボニル、アリールオキシカルボニル、アミノカルボニル、及び置換アミノカルボニル、からなる群より選択され、
B、D、及びEは、独立してN又はそれぞれC−R2、C−R3及びC−R4であり、R2、R3及びR4は、独立に、水素、置換もしくは未置換アルキル、アルケニル、アルキニル、シクロアルキル、ヘテロシクロアルキル、アリールアルキル、アリール、ヘテロアリール、ヒドロキシ、アルキルオキシ、アリールオキシ、ヘテロアリールオキシ、アシルオキシ、アリールアシルオキシ、ヘテロアリールアシルオキシ、アルキルスルホニルオキシ、アリールスルホニルオキシ、チオ、アルキルチオ、アリールチオ、アミノ、アルキルアミノ、ジアルキルアミノ、シクロアルキルアミノ、ヘテロシクロアルキルアミノ、アリールアミノ、ヘテロアリールアミノ、アシルアミノ、アリールアシルアミノ、ヘテロアリールアシルアミノ、アルキルスルホニルアミノ、アリールスルホニルアミノ、アシル、アリールアシル、ヘテロアリールアシル、アルキルスルフィニル、アリールスルフィニル、アルキルスルホニル、アリールスルホニル、アミノスルホニル、置換アミノスルホニル、カルボキシ、アルコキシカルボニル、シクロアルキルオキシカルボニル、アリールオキシカルボニル、カルバモイル、置換カルバモイル、ハロゲン、シアノ、イソシアノ及びニトロ、からなる群より選択されるか、又はR2とR3もしくはR3とR4は、それらが結合している炭素と共に、置換された環もしくは未置換の環を形成してもよく、これらの環は、芳香族であっても、非芳香族であってもよく、および、前記環中に、1個又は複数個のヘテロ原子を含んでもよく、および、芳香族環又は脂肪族環と融合していてもよく、および、
R10及びR11は、独立に、水素、アルキル、アルケニル、アルキニル、シクロアルキル、ヘテロシクロアルキル、アリールアルキル、アリール、ヘテロアリール、アシル、アリールアシル、ヘテロアリールアシル、スルホニル、アミノスルホニル、置換アミノスルホニル、アルコキシカルボニル、シクロアルキルオキシカルボニル、アリールオキシカルボニル、カルバモイル及び置換カルバモイル、からなる群より選択され、ただし、R10とR11の両方が水素であることはない、
化合物又は薬学的に許容可能なその塩。 The following general formula III
Wherein X is selected from the group consisting of O, S and N—R ′, wherein R ′ is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, arylalkyl, aryl, heteroaryl, acyl, Selected from the group consisting of arylacyl, heteroarylacyl, sulfonyl, aminosulfonyl, substituted aminosulfonyl, alkoxycarbonyl, cycloalkyloxycarbonyl, aryloxycarbonyl, carbamoyl and substituted carbamoyl,
R is halogen, cyano, isocyano, nitro, amino, alkylamino, dialkylamino, cycloalkylamino, heterocycloalkylamino, arylamino, heteroarylamino, acylamino, arylacylamino, heteroarylacylamino, alkylsulfonylamino, Selected from the group consisting of arylsulfonylamino, hydroxysulfonyl, aminosulfonyl, substituted aminosulfonyl, acyl, arylacyl, heteroarylacyl, carboxy, alkoxycarbonyl, cycloalkyloxycarbonyl, aryloxycarbonyl, aminocarbonyl, and substituted aminocarbonyl And
B, D and E are independently N or C—R 2 , C—R 3 and C—R 4 respectively , and R 2 , R 3 and R 4 are independently hydrogen, substituted or unsubstituted Alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, arylalkyl, aryl, heteroaryl, hydroxy, alkyloxy, aryloxy, heteroaryloxy, acyloxy, arylacyloxy, heteroarylacyloxy, alkylsulfonyloxy, arylsulfonyloxy, Thio, alkylthio, arylthio, amino, alkylamino, dialkylamino, cycloalkylamino, heterocycloalkylamino, arylamino, heteroarylamino, acylamino, arylacylamino, heteroarylacylamino, a Killsulfonylamino, arylsulfonylamino, acyl, arylacyl, heteroarylacyl, alkylsulfinyl, arylsulfinyl, alkylsulfonyl, arylsulfonyl, aminosulfonyl, substituted aminosulfonyl, carboxy, alkoxycarbonyl, cycloalkyloxycarbonyl, aryloxycarbonyl, Selected from the group consisting of carbamoyl, substituted carbamoyl, halogen, cyano, isocyano and nitro, or R 2 and R 3 or R 3 and R 4 together with the carbon to which they are attached, a substituted ring or Unsubstituted rings may be formed, these rings may be aromatic or non-aromatic, and may contain one or more heteroatoms in the ring. Well and aromatic ring or It may be fused with an aliphatic ring, and,
R 10 and R 11 are independently hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, arylalkyl, aryl, heteroaryl, acyl, arylacyl, heteroarylacyl, sulfonyl, aminosulfonyl, substituted aminosulfonyl , Alkoxycarbonyl, cycloalkyloxycarbonyl, aryloxycarbonyl, carbamoyl and substituted carbamoyl, provided that both R 10 and R 11 are not hydrogen,
A compound or a pharmaceutically acceptable salt thereof.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/708,224 US20130129677A1 (en) | 2009-02-27 | 2012-12-07 | Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections |
US13/708,224 | 2012-12-07 | ||
PCT/US2013/073449 WO2014089378A1 (en) | 2012-12-07 | 2013-12-06 | Thienopyridine derivatives for the treatment and prevention of dengue virus infections |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2016501883A JP2016501883A (en) | 2016-01-21 |
JP2016501883A5 true JP2016501883A5 (en) | 2016-11-17 |
Family
ID=50884015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015545858A Pending JP2016501883A (en) | 2012-12-07 | 2013-12-06 | Thienopyridine derivatives for the treatment and prevention of dengue virus infection |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2928470A4 (en) |
JP (1) | JP2016501883A (en) |
CA (1) | CA2893318A1 (en) |
WO (1) | WO2014089378A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105418635A (en) * | 2015-12-25 | 2016-03-23 | 上海应用技术学院 | Synthesis method of thienopyridine medical intermediate |
CN105832734B (en) * | 2016-03-31 | 2018-05-04 | 南通江海港建设工程有限公司 | A kind of purposes of compound in platelet concentration medicine is increased |
CN105769866B (en) * | 2016-03-31 | 2018-05-04 | 南通江海港建设工程有限公司 | A kind of purposes of compound in platelet concentration medicine is increased |
WO2017217439A1 (en) * | 2016-06-14 | 2017-12-21 | 国立大学法人東京大学 | THIENO[2,3-b]PYRIDINE DERIVATIVE AND QUINOLINE DERIVATIVE, AND USE THEREOF |
AU2018361971A1 (en) | 2017-11-03 | 2020-06-04 | Universite De Montreal | Compounds and use thereof in the expansion of stem cells and/or progenitor cells |
JP7445609B2 (en) * | 2018-06-06 | 2024-03-07 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | Thieno[2,3-B]pyridine derivatives as EPAC inhibitors and their pharmaceutical uses |
US20220332720A1 (en) * | 2019-08-21 | 2022-10-20 | The Scripps Research Institute | Bicyclic agonists of stimulator of interferon genes sting |
WO2021108999A1 (en) * | 2019-12-03 | 2021-06-10 | 辽宁凯莱英医药化学有限公司 | Method for continuous synthesis of 4-ethoxy-1,1,1-trifluoro-3-buten-2-one |
CN111072463A (en) * | 2019-12-03 | 2020-04-28 | 辽宁凯莱英医药化学有限公司 | Continuous synthesis method of 4-ethoxy-1, 1, 1-trifluoro-3-butene-2-one |
EP4164637A1 (en) * | 2020-06-12 | 2023-04-19 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Thienopyridine derivatives for use in the treatment of coronavirus infection |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996009296A1 (en) * | 1994-09-22 | 1996-03-28 | Rational Drug Design Laboratories | Arylthiadiazole derivative and antiviral agent containing the same |
GB9717576D0 (en) * | 1997-08-19 | 1997-10-22 | Xenova Ltd | Pharmaceutical compounds |
US6608053B2 (en) * | 2000-04-27 | 2003-08-19 | Yamanouchi Pharmaceutical Co., Ltd. | Fused heteroaryl derivatives |
US7202363B2 (en) * | 2003-07-24 | 2007-04-10 | Abbott Laboratories | Thienopyridine and furopyridine kinase inhibitors |
AR048669A1 (en) * | 2004-03-03 | 2006-05-17 | Syngenta Ltd | BISAMIDE BICYCLE DERIVATIVES |
SE0403171D0 (en) * | 2004-12-23 | 2004-12-23 | Astrazeneca Ab | New compounds |
JP2006298909A (en) * | 2005-03-25 | 2006-11-02 | Tanabe Seiyaku Co Ltd | Medicine composition |
AU2007254165A1 (en) * | 2006-05-17 | 2007-11-29 | Forschungsverbund Berlin E.V. | Pyrimidine low molecular weight ligands for modulating hormone receptors |
BRPI1005828A2 (en) * | 2009-02-27 | 2017-07-18 | Siga Tech Inc | pharmaceutical composition; method for treating or prophylaxis of a viral infection or disease associated therewith; compound; a method for preparing a mixture of tert-butyl (4e) -4- (hydroxymethylene) -5-oxoazepane-1-carboxylate and tert-butyl (3e) -3- (hydroxymethylene) -4-oxoazepane-1-carboxylate; method for the preparation of a mixture of tert-butyl 3-cyano-2-thioxo-1,2,5,6,8,9-hexahydro-1h-pyrido [2,3-d] azepine-7-carboxylate and tert butyl 3-cyano-2-thioxo-1,2,5,7,8,9-hexahydro-6h-pyrido [3,2-c] azepine-6-carboxylate; Method for the preparation of 3-amino-7-tert-butyloxycarbonyl-6,7,8,9-tetrahydro-5h-1-thia-7,10-diaza-cyclohepta [f] indene-2-carboxylic acid (5- phenyl- [1,3,4] thiazol-2-yl) -amide; method for the preparation of 3-amino-6,7,8,9-tetrahydro-5h-1-thia-7,10-diaza-cyclohepta [f] indene-2-carboxylic acid (5-phenyl- [1,3 , 4] thiadiazol-2-yl) -amide; Method for the preparation of 3-amino-6-tertbutyloxycarbonyl-6,7,8,9-tetrahydro-5h-1-thia-6,10-diaza-cyclohepta [f] indene-2-carboxylic acid [1,3,4] thiadiazol-2-yl) -amide and method for the preparation of 3-amino-6,7,8,9-tetrahydro-5h-1-thia-6,10-diaza-cyclohepta acid [ f] indene-2-carboxylic (5-phenyl- [1,3,4] thiadiazol-2-yl) -amide |
US20130129677A1 (en) * | 2009-02-27 | 2013-05-23 | Siga Technologies, Inc. | Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections |
US8785499B2 (en) * | 2009-07-10 | 2014-07-22 | University Of Maryland, Baltimore | Targeting NAD biosynthesis in bacterial pathogens |
-
2013
- 2013-12-06 JP JP2015545858A patent/JP2016501883A/en active Pending
- 2013-12-06 CA CA2893318A patent/CA2893318A1/en not_active Abandoned
- 2013-12-06 EP EP13859644.0A patent/EP2928470A4/en not_active Withdrawn
- 2013-12-06 WO PCT/US2013/073449 patent/WO2014089378A1/en active Application Filing
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2016501883A5 (en) | ||
KR102534028B1 (en) | Triazolopyrimidine compounds and uses thereof | |
TWI699359B (en) | 4h-pyrrolo[3,2-c]pyridin-4-one derivatives | |
CN101528743B (en) | Fused heterocyclic derivatives and methods of use | |
AU2011330730B2 (en) | Substituted 4-(selenophen-2(or 3)-ylamino)pyrimidine compounds and methods of use thereof | |
EP1682547B1 (en) | Rsv polymerase inhibitors | |
DK2526090T3 (en) | New antimalarials | |
JP2021503458A5 (en) | ||
JP2016522246A5 (en) | ||
RU2018123779A (en) | New connections | |
RU2011116230A (en) | PYRAZOLOPYRIDINE DERIVATIVES AS NADPH-OXIDASE INHIBITORS | |
JP2011510995A5 (en) | ||
CN106458930A (en) | 2-aminopyrimidine compound and pharmaceutical composition and use thereof | |
RU2008110913A (en) | NEW IMIDAZO [4,5-b] PYRIMIDINE DERIVATIVES AS Glycogen Synthase 3 KINASE INHIBITORS FOR APPLICATION IN TREATMENT OF DEMENTIA AND NEURODEGENERATIVE DISORDERS | |
JP2017510644A5 (en) | ||
WO2012037108A1 (en) | Aminoquinoline derivatives as antiviral agents | |
JP2006520805A5 (en) | ||
CN105777756A (en) | Heteroaryl compound and application thereof in medicines | |
JP2018501315A5 (en) | ||
WO2012087938A1 (en) | Quinazolinone derivatives as antiviral agents | |
EP2920177A1 (en) | Compounds and compositions for the treatment of parasitic diseases | |
AU2005215257A1 (en) | Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists | |
JP2017532360A5 (en) | ||
JP2017501983A5 (en) | ||
JP2016501185A5 (en) |